McDaniel, J.H., Patel, V., Olson, N.D., He, H., He, Z., Cole, K.D., Schmitt, A., Sikkink, K., Sedlazeck, F.J., Doddapaneni, H., Jhangiani, S.N., Muzny, D.M., Gingras, M., Mehta, H., Paulin, L.F., Hastie, A.R., Yu, H., Weigman, V., Rojas, A., Kennedy, K., Remington, J., Gonzalez, I., Sudkamp, M., Wiseman, K., Lajoie, B.R., Levy, S., Jain, M., Akeson, S., Narzisi, G., Steinsnyder, Z., Reeves, C., Shelton, J., Kingan, S.B., Lambert, C., Bayabyan, P., Wenger, A.M., McLaughlin, I.J., Adamson, A., Kingsley, C., Wescott, M., Kim, Y., Paten, B., Park, J., Violich, I., Miga, K.H., Gardner, J., McNulty, B., Rosen, G., McCoy, R., Brundu, F., Sayyari, E., Scheffler K., Truong, S., Catreux, S., Hannah, L.C., Lipson, D., Benjamin, H., Iremadze, N., Soifer, I., Eacker, S., Wood, M., Cross, E., Husar, G., Gross, S., Vernich, M., Kolmogorov, M., Ahmad, T., Keskus, A., Bryant, A., Thibaud-Nissen, F., Trow, J., Proszynski, J., Hirschberg, J.W., Ryon, K., Mason, C.E., Wagner, J., Xiao, C., Liss, A.S., Zook, J.M. (2024). Development and extensive sequencing of a broadly-consented Genome in a Bottle matched tumor-normal pair. Preprint.
David, J.K., Maden, S.K., Wood, M.A., Thompson, R.F., Nellore, A. (2022). Retained introns in long RNA-seq reads are not reliably detected in sample-matched short reads. Genome Biology. 23, 240.
Guan, X., Polesso, F., Wang, C., Sehrawat, A., Hawkins, R.M., Murray, S.E., Thomas, G., Caruso, B., Thompson, R.F., Wood, M.A., Hipfinger, C., Hammond, S.A., Graff, J.N., Xia, Z., Moran, A.E. (2022). Androgen receptor activity in T cells limits checkpoint blockade efficacy. Nature. 606, 791-796.
Gordon, N.S., Baxter, L.A., Goel, A., Arnold, R., Kaur, B., Liu, W., Pirrie, S.J., Hussain, S., Viney, R., Ford, D., Zarkar, A., Wood, M.A., Mitin, T., Thompson, R.F., James, N.D., Ward, D.G., Bryan, R.T. (2021). Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: A pilot study. BJU International. 129, 32-34.
Weeder, B.R., Wood, M.A., Li, E., Nellore, A., Thompson, R.F. (2021) Pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identification. Bioinformatics. 37(21), 3723-3733.
Fuiten, A.M., Fankhauser, R.G., Smit, D.J., Stark, M.S., Enright, T.F., Wood, M.A., DePatie, N.A., Pivik, K., Sturm, R.A., Berry, E.G., Kulkarni, R.P. (2021). Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosa. Pigment Cell & Melanoma Research. 00, 1-8.
Graff, J.N., Alumkal, J.J., Thomas, G.V., Thompson, R.F., Moran, A.E., Wood, M.A., Drake, C.G., Slottke, R.E., Beer, T.M. (2020). A Phase II, Single-Arm Study of Pembrolizumab with Enzalutamide in Men with Metastatic Castration Resistant Prostate Cancer Progressing on Enzalutamide Alone. Journal for ImmunoTherapy of Cancer. 8:e000642.
Nguyen, A., David, J.K., Maden S.K., Wood M.A., Weeder, B.R., Nellore, A., Thompson, R.F. (2020). Human leukocyte antigen susceptibility map for SARS-CoV-2. Journal of Virology. JVI.00510-20.
Wood, M.A., Weeder, B.R., David, J.K., Nellore, A., Thompson, R.F. (2020). Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival. Genome Medicine, 12, 33.
Wood, M.A., Nguyen, A., Struck, A.J., Ellrott, K., Nellore, A., Thompson, R.F. (2020). neoepiscope improves neoepitope prediction with multi-variant phasing. Bioinformatics, 36(3), 713-720.
Wood, M.A., Nellore, A., Thompson, R.F. (2019). Tumor Mutation Burden – From Doubts to Concerns. JAMA Oncology, 5(12), 1808-1809.
Wood, M.A., Paralkar, M., Paralkar, M.P., Nguyen, A., Struck, A.J., Ellrott, K., Margolin, M., Nellore, A., Thompson, R.F. (2018). Population-level distribution and putative immunogenicity of cancer neoepitopes. BMC Cancer, 18, 414.